Bayer had its worst day ever as shares sunk to the lowest in over a decade
Krisztian Bocsi/Bloomberg via Getty Images
Posted
Tim Loh, Bloomberg (via Fortune)
The German pharma and agriculture company stopped the main study of its top experimental medicine due to a lack of efficacy and lost a key US trial against its weed killer Roundup. Read More
